Strategic Acquisition Cantel Medical is now part of STERIS, signaling potential cross-sell opportunities for sterilization, infection prevention, and equipment lifecycle services across broader customer bases and geographies.

Integrated Solutions Recent acquisitions including Hu-Friedy and Omnia, plus collaboration on endoscope reprocessing software, suggest opportunities to offer bundled infection prevention, dental consumables, and software-enabled workflow enhancements.

Infection Control Focus With a clear emphasis on infection prevention products and services, target healthcare providers and facilities updating reprocessing, sterilization, and disinfection programs to drive higher adoption of Cantel/STERIS offerings.

Growth Through Tech Investments in software solutions for endoscope reprocessing indicate a upsell path for fleet management, data analytics, and compliance tooling to modernize customers’ infection control tech stacks.

Global Reach, Mid-Sized Cantel operates globally with a mid-market employee base; leverage mid-size healthcare systems and regional distributors as entry points for expanded product lines and cross-sell within the STERIS ecosystem.